AMARIN CORP PLC\UK

AMRN ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $181.1M $130.1M $81.8M $54.2M $26.4M
Cost of Revenue $45.0M $34.4M $27.9M $20.5M $11.9M
Gross Profit $136.2M $95.7M $53.9M $33.7M $14.4M
Gross Margin 75.2% 73.6% 65.9% 62.2% 54.8%
Operating Expenses
Research & Development $47.2M $50.0M $51.1M $50.3M $72.8M $59.0M $21.6M $28.0M
SG&A Expense $134.5M $111.4M $101.0M $79.3M $123.8M $57.8M $22.6M $17.1M
Operating Income $-45.6M $-65.6M $-98.2M $-96.0M $-182.1M $-116.8M $-44.2M $-45.1M
Operating Margin -25.2% -50.4% -120.1% -177.0% -691.1%
Interest Expense $9.8M $18.7M $20.2M $18.6M $34.2M $18.1M $1.0K $19.0K
Pretax Income $-54.8M $-76.4M $-118.3M $-59.2M $-169.4M $-170.1M $-66.6M $-250.1M
Income Tax Expense $13.0M $10.0M $-3.1M $-2.8M $-3.2M $9.1M $2.5M $-501.0K
Net Income $-67.9M $-86.4M $-115.2M $-56.4M $-166.2M $-179.2M $-69.1M $-249.6M
Net Margin -37.5% -66.4% -140.9% -104.0% -630.8%
EPS (Basic) $-0.25 $-0.41 $-0.83 $-0.32 $-1.03 $-1.24 $0.00 $0.00
EPS (Diluted) $-0.25 $-0.41 $-0.83 $-0.36 $-1.28 $-1.24 $0.00 $0.00
Shares Outstanding (Basic) 270.7M 211.9M 180.7M 173.7M 161.0M 144.0M 144.1M 118.16B
Shares Outstanding (Diluted) 270.7M 211.9M 180.7M 173.8M 167.1M 144.0M 144.1M 118.16B
Dividends Per Share
← Newer Page 2 of 3 Older →